Get started
DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001

DYNAVAX TECHNOLOGIES CORP COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

0IDA chart


Full chart

0IDA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.71 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
94.280
Basic EPS (TTM)
0.155 USD
Net income (FY)
‪−6.39 M‬ USD
Revenue (FY)
‪232.28 M‬ USD
Shares float
‪130.82 M‬
Beta (1Y)
0.25

Employees


Employees (FY)
408
Change (1Y)
+57 +16.24%
Revenue / Employee (1Y)
‪569.32 K‬ USD
Net income / Employee (1Y)
‪−15.66 K‬ USD

About Dynavax Technologies Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Ryan Spencer
Website
dynavax.com
Headquarters
Emeryville
Founded
1996
FIGI
BBG00JVRNHP4
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0IDA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

0IDA highest yielding bonds


DVAX5420600
Dynavax Technologies Corporation 2.5% 15-MAY-2026
Yield to maturity
−9.30%
Maturity date
May 15, 2026

Explore more bonds 

Frequently Asked Questions


The current price of 0IDA is 13.165 USD — it has increased by 7.16% in the past 24 hours. Watch DYNAVAX TECHNOLOGIES CORP COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange DYNAVAX TECHNOLOGIES CORP COM USD0.001 stocks are traded under the ticker 0IDA.
0IDA stock has risen by 9.43% compared to the previous week, the month change is a 23.96% rise, over the last year DYNAVAX TECHNOLOGIES CORP COM USD0.001 has showed a −0.11% decrease.
We've gathered analysts' opinions on DYNAVAX TECHNOLOGIES CORP COM USD0.001 future price: according to them, 0IDA price has a max estimate of 29.00 USD and a min estimate of 15.00 USD. Watch 0IDA chart and read a more detailed DYNAVAX TECHNOLOGIES CORP COM USD0.001 stock forecast: see what analysts think of DYNAVAX TECHNOLOGIES CORP COM USD0.001 and suggest that you do with its stocks.
0IDA reached its all-time high on Nov 4, 2021 with the price of 21.335 USD, and its all-time low was 4.095 USD and was reached on Nov 9, 2020. View more price dynamics on 0IDA chart.
See other stocks reaching their highest and lowest prices.
0IDA stock is 10.42% volatile and has beta coefficient of 0.25. Track DYNAVAX TECHNOLOGIES CORP COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is DYNAVAX TECHNOLOGIES CORP COM USD0.001 there?
Today DYNAVAX TECHNOLOGIES CORP COM USD0.001 has the market capitalization of ‪1.71 B‬, it has increased by 11.98% over the last week.
Yes, you can track DYNAVAX TECHNOLOGIES CORP COM USD0.001 financials in yearly and quarterly reports right on TradingView.
DYNAVAX TECHNOLOGIES CORP COM USD0.001 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
0IDA earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.11 USD resulting in a 5.89% surprise. The estimated earnings for the next quarter are 0.04 USD per share. See more details about DYNAVAX TECHNOLOGIES CORP COM USD0.001 earnings.
DYNAVAX TECHNOLOGIES CORP COM USD0.001 revenue for the last quarter amounts to ‪80.63 M‬ USD, despite the estimated figure of ‪84.17 M‬ USD. In the next quarter, revenue is expected to reach ‪71.71 M‬ USD.
0IDA net income for the last quarter is ‪17.59 M‬ USD, while the quarter before that showed ‪11.39 M‬ USD of net income which accounts for 54.52% change. Track more DYNAVAX TECHNOLOGIES CORP COM USD0.001 financial stats to get the full picture.
No, 0IDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 408.00 employees. See our rating of the largest employees — is DYNAVAX TECHNOLOGIES CORP COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DYNAVAX TECHNOLOGIES CORP COM USD0.001 EBITDA is ‪496.00 K‬ USD, and current EBITDA margin is −11.53%. See more stats in DYNAVAX TECHNOLOGIES CORP COM USD0.001 financial statements.
Like other stocks, 0IDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DYNAVAX TECHNOLOGIES CORP COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DYNAVAX TECHNOLOGIES CORP COM USD0.001 technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DYNAVAX TECHNOLOGIES CORP COM USD0.001 stock shows the buy signal. See more of DYNAVAX TECHNOLOGIES CORP COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.